論文（英文）

• Kanda M, Oba K, Aoyama T, Kashiwabara K, Mayanagi S, Maeda H, Honda M, Hamada C, Sadahiro S, Sakamoto J, Saji S, Yoshikawa T. Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials. Dis Colon Rec 2017. Accepted on 31 Oct 2017.
• Kawai K, Nozawa H, Hata K, Tanaka T, Nishikawa T, Oba K, Watanabe T. Optimal interval for 18F-FDG-PET after chemoradiotherapy for rectal cancer. Clin Colorectal Cancer. Available online 21 November 2017
• Oba K, Horie N, Sato N, Saito K, Takeuchi T, Mimori T, Miyasaka N, Koike T, Tanaka Y. Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis. Contemp Clin Trials Commun 2017;8:49-54.
• Maeda H, Okamoto K, Oba K, Kobayashi M. Lymph node retrieval using fat dissolution technique after surgical resection of colorectal cancer: a protocol paper. Ann Can Res Ther 2017; 25: 90-1.
• Takaku T, Iriyama N, Mitsumori T, Sato E, Gotoh A, Kirito K, Noguchi M, Koike M, Sakamoto J, Oba K, Komatsu N. Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group. Oncology. 2017 Nov 18. doi: 10.1159/000481945. [Epub ahead of print]
• Okuno K, Aoyama T, Oba K, Yokoyama N, Matsuhashi N, Kunieda K, Nishimura Y, Akamatsu H, Kobatake T, Morita S, Yoshikawa T, Sakamoto J, Saji S. Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial). Cancer Chemother Pharmacol. 2017 Nov 1. doi: 10.1007/s00280-017-3466-7. [Epub ahead of print]
• Maeda H, Kashiwabara K, Aoyama T, Oba K, Honda M, Mayanagi S, Kanda M, Hamada C, Sadahiro S, Sakamoto J, Saji S, Yoshikawa T. Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) clinical trials. J Cancer 2017; 8(19): 4057–4064.
• Murai K, Yamaguchi K, Ito S, Miyagishima T, Shindo M, Wakasa K, Inomata M, Nagashima T, Kondo T, Fujimoto N, Yamamoto S, Yonezumi M, Oyake T, Kowata S, Tsukushi Y, Mine T, Meguro K, Ikeda K, Watanabe R, Saito S, Sato S, Tajima K, Chou T, Kubo K, Oba K, Sakamoto J, Ishida Y; The Inter-Michinoku Dasatinib Study Group (IMIDAS). Rapid reduction in BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patients. Eur J Haematol. 2017 Sep 12. doi: 10.1111/ejh.12969. [Epub ahead of print]
• Arakawa K, Kawai K, Ishihara S, Hata K, Nozawa H, Oba K, Sugihara K, Watanabe T. Prognostic Significance of Peritoneal Metastasis in Stage IV Colorectal Cancer Patients With R0 Resection: A Multicenter, Retrospective Study. Dis Colon Rectum 2017;60:1041-1049.
• Kawahara T, Shimozuma K, Shiroiwa T, Hagiwara Y, Uemura Y, Watanabe T, Taira N, Fukuda T, Ohashi Y, Mukai H. Patient-reported outcome results from the open-label randomized phase III SELECT BC trial evaluating first-line S-1 therapy for metastatic breast cancer. Oncology. 2018;94:107-115
• Shiroiwa T, Fukuda T, Shimozuma K, Mouri M, Hagiwara Y, Kawahara T, Ohsumi S, Hozumi Y, Sagara Y, Ohashi Y, Mukai H. Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial. BMC Cancer. 2017;17:773.
• Hiraoka A, Michitaka K, Kumada T, Izumi N, Kadoya M, Kokudo N, Kubo S, Matsuyama Y, Nakashima O, Sakamoto M, Takayama T, Kokudo T, Kashiwabara K, Kudo M, The Liver Cancer Study Group of Japan. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer 2017; 6(4): 325–336.
• Sato Y, Sano S, Nakao Y, Morii J, Kashiwabara K. Surgical strategy and retrospective analysis of staged posterior osteotomy for adult spinal deformities. Journal of Spine Research 2017; 8(7): 1222–1226.
• Aoyama T, Kashiwabara K, Oba K, Honda M, Sadahiro S, Hamada C, Maeda H, Mayanagi S, Kanda M, Sakamoto J, Saji S, Yoshikawa T. Clinical impact of tumor location on the colon cancer survival and recurrence: analyses of pooled data from three large phase III randomized clinical trials. Cancer Medicine 2017; 6(11): 2523-2530. Doi: 10.1002/cam4.1126.
• Karasaki T, Nagayama K, Kuwano H, Nitadori J, Sato M, Anraku M, Hosoi A, Matsushita H, Morishita Y, Kashiwabara K, Takazawa M, Ohara O, Kakimi K, Nakajima J. An immunogram for the cancer-immunity cycle: towards personalized immunotherapy of lung cancer. Journal of Thoracic Oncology 2017; 12(5): 791–803. Doi: 10.1016/j.jtho.2017.01.005.
• Kuramitsu S, Sonoda S, Shinozaki T, Jinnouchi H, Muraoka Y, Domei T, Hyodo M, Shirai S, Ando K, Otsuji Y. Impact of lesion complexity and overlapping segments on long-term vascular response to cobalt-chromium everolimus-eluting stent: five-year follow-up optical coherence tomography study. Heart Vessels. 2018;33(4):341-50.
• Hagiwara Y, Shiroiwa T, Shimozuma K, Kawahara T, Uemura Y, Watanabe T, Taira N, Fukuda T, Ohashi Y, Mukai H. Impact of adverse events on health utility and health-related quality of life in patients receiving first-line chemotherapy for metastatic breast cancer: results from the SELECT BC study. Pharmacoeconomics. 2018;36:215-223.
• Niikura R, Hirata Y, Suzuki N, Yamada A, Hayakawa Y, Suzuki H, Yamamoto S, Nakata R, Komatsu J, Okamoto M, Kodaira M, Shinozaki T, Fujishiro M, Watanabe T, Koike K. Colonoscopy reduces colorectal cancer mortality: a multicenter, long-term, colonoscopy-based cohort study. PLoS One. 2017;12(9):e0185294.
• Yamaguchi R, Makino Y, Chiba F, Torimitsu S, Yajima D, Inokuchi G, Motomura A, Hashimoto M, Hoshioka Y, Shinozaki T, Iwase H. Frequency of cardiopulmonary resuscitation-related injuries and the factors involved during the 2010 Guidelines period: a retrospective autopsy- and post-mortem computed tomography-based study. Int J Legal Med. 2017;131(6):1655-63.
• Jinnouchi H, Kuramitsu S, Shinozaki T, Hiromasa T, Kobayashi Y, Takeji Y, Miura M, Masuda H, Matsumura Y, Yamaji Y, Sakakura K, Domei T, Soga Y, Hyodo M, Shirai S, Ando K. Five-year clinical outcomes after drug-eluting stent implantation following rotational atherectomy for heavily calcified lesions. Circ J. 2018;82(4):983-91.

TOP